Cerebrospinal beta-amyloid (1–42) in early Alzheimer's disease: association with apolipoprotein E genotype and cognitive decline

Clinical diagnosis of Alzheimer's disease

Guy M. McKhann, David A. Drachman, Marshall Folstein et al. · Neurology · 1984 · 27.8K citations · Full text

Vascular dementia

Gustavo C. Román, T. K. Tatemichi, Timo Erkinjuntti et al. · Neurology · 1993 · 4.9K citations

Cerebrovascular Disease, Neurovascular Disease, Stroke Rehabilitation +17

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.

D. E. Schmechel, Ann M. Saunders, Warren J. Strittmatter et al. · Proceedings of the National Academy of Sciences · 1993 · 1.5K citations · Full text

Neurochemical Biomarkers, Alzheimer's Disease, Protein Misfolding +19

Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions

G. William Rebeck, Joell S. Reiter, Dudley K. Strickland et al. · Neuron · 1993 · 1.1K citations

Receptor Interactions, Alzheimer's Disease, Apolipoprotein E +8

Improved discrimination of AD patients using β-amyloid _(1-42) and tau levels in CSF

Frank Hulstaert, Kaj Blennow, Adrian Ivanoiu et al. · Neurology · 1999 · 726 citations · Full text